MetLife (MET) to Release Quarterly Earnings on Wednesday

MetLife (NYSE:METGet Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $2.00 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing the consensus estimate of $1.95 by ($0.02). MetLife had a net margin of 2.36% and a return on equity of 19.48%. The firm had revenue of $18.72 billion for the quarter, compared to the consensus estimate of $18.07 billion. On average, analysts expect MetLife to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

MetLife Trading Up 0.4 %

Shares of MetLife stock opened at $72.23 on Wednesday. The stock has a fifty day simple moving average of $71.28 and a 200 day simple moving average of $67.02. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.53. MetLife has a 12-month low of $48.95 and a 12-month high of $74.68. The company has a market capitalization of $52.22 billion, a P/E ratio of 39.47, a price-to-earnings-growth ratio of 0.53 and a beta of 1.04.

MetLife Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 11th. Shareholders of record on Tuesday, May 7th will be given a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 3.02%. This is a boost from MetLife’s previous quarterly dividend of $0.52. MetLife’s payout ratio is currently 113.66%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Piper Sandler upped their price target on MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a research report on Friday, April 5th. UBS Group decreased their target price on MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a research note on Monday, February 5th. Keefe, Bruyette & Woods upped their target price on MetLife from $82.00 to $87.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 10th. Wells Fargo & Company increased their price objective on MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Finally, Morgan Stanley increased their price objective on MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research report on Monday, April 15th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $79.23.

Check Out Our Latest Report on MetLife

Insider Activity at MetLife

In other news, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares in the company, valued at approximately $4,174,893.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other MetLife news, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the sale, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the sale, the insider now directly owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The disclosure for this sale can be found here. 0.32% of the stock is owned by company insiders.

About MetLife

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Earnings History for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.